Balance Sheet
Cash Flow Statement
AmortizationOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Depreciation and Depletion (2016 - 2022)

Historic Depreciation and Depletion for RedHill Biopharma (RDHL) over the last 11 years, with Q4 2022 value amounting to $491000.0.

  • RedHill Biopharma's Depreciation and Depletion rose 935.41% to $491000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $2.1 million, marking a year-over-year increase of 1165.71%. This contributed to the annual value of $588000.0 for FY2024, which is 5930.8% down from last year.
  • RedHill Biopharma's Depreciation and Depletion amounted to $491000.0 in Q4 2022, which was up 935.41% from $491000.0 recorded in Q3 2022.
  • Over the past 5 years, RedHill Biopharma's Depreciation and Depletion peaked at $617000.0 during Q2 2022, and registered a low of $22000.0 during Q1 2018.
  • Its 5-year average for Depreciation and Depletion is $342350.0, with a median of $433000.0 in 2020.
  • As far as peak fluctuations go, RedHill Biopharma's Depreciation and Depletion tumbled by 1538.46% in 2018, and later soared by 120909.09% in 2019.
  • Over the past 5 years, RedHill Biopharma's Depreciation and Depletion (Quarter) stood at $23000.0 in 2018, then skyrocketed by 1000.0% to $253000.0 in 2019, then surged by 86.96% to $473000.0 in 2020, then fell by 5.07% to $449000.0 in 2021, then grew by 9.35% to $491000.0 in 2022.
  • Its last three reported values are $491000.0 in Q4 2022, $491000.0 for Q3 2022, and $617000.0 during Q2 2022.